Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

The herbal mixture RAA promotes hair growth and could be an alternative treatment for hair loss.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

A woman with severe angioedema improved significantly after treatment with rituximab.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Human keratinocytes do not naturally respond to androgens.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Androgens may influence bladder cancer progression by affecting cellular behavior.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Fixing DNA errors is crucial to prevent skin cancer.

Increasing XIAP and DDRGK1 can help prevent hearing loss from loud noise.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

Nuclear AR levels give better insight into hormone effects in skin conditions.